Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Background: Malaria caused by Plasmodium falciparum in pregnancy can result in adverse maternal and fetal sequelae. This review evaluated the adherence of the national guidelines drawn from World Health Organization (WHO) regions, Africa, Eastern Mediterranean, Southeast Asia, and Western Pacific, to the WHO recommendations on drug treatment and prevention of chloroquine-resistant falciparum malaria in pregnant women. Methods: Thirty-five updated national guidelines and the President’s Malaria Initiative (PMI), available in English language, were reviewed. The primary outcome measures were the first-line anti-malarial treatment protocols adopted by national guidelines for uncomplicated and complicated falciparum malaria infections in early (first) and late (second and third) trimesters of pregnancy. The strategy of intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) was also addressed. Results: This review evaluated the treatment and prevention of falciparum malaria in pregnancy in 35 national guidelines/PMI-Malaria Operational Plans (MOP) reports out of 95 malaria-endemic countries. Of the 35 national guidelines, 10 (28.6%) recommend oral quinine plus clindamycin as first-line treatment for uncomplicated malaria in the first trimester. As the first-line option, artemether–lumefantrine, an artemisinin-based combination therapy, is adopted by 26 (74.3%) of the guidelines for treating uncomplicated or complicated malaria in the second and third trimesters. Intravenous artesunate is approved by 18 (51.4%) and 31 (88.6%) guidelines for treating complicated malaria during early and late pregnancy, respectively. Of the 23 national guidelines that recommend IPTp-SP strategy, 8 (34.8%) are not explicit about directly observed therapy requirements, and three-quarters, 17 (73.9%), do not specify contra-indication of SP in human immunodeficiency virus (HIV)-infected pregnant women receiving cotrimoxazole prophylaxis. Most of the guidelines (18/23; 78.3%) state the recommended folic acid dose. Conclusion: Several national guidelines and PMI reports require update revisions to harmonize with international guidelines and emergent trends in managing falciparum malaria in pregnancy. National guidelines and those of donor agencies should comply with those of WHO guideline recommendations although local conditions and delayed guideline updates may call for deviations from WHO evidence-based guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Malaria in pregnancy can be particularly severe, and artesunate has become the treatment of choice for all trimesters [130, 131].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These measures include IPTp-SP, the use of ITNs and the use of IRS in conjunction with nutritional interventions [130, 160, 181, 194].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,007
McGregor, I. A., Wilson, M. E., & Billewicz, W. Z. (1983) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(83)90081-0 · Cited by 393
Malaria during pregnancy in an area of unstable endemicity.
Nosten, F., ter Kuile, F., Maelankirri, L., Decludt, B., & White, N. J. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90205-d · Cited by 294
van der Pluijm, R. W., Tripura, R., Hoglund, R. M., Pyae Phyo, A., Lek, D., ul Islam, A., Anvikar, A. R., Satpathi, P., Satpathi, S., Behera, P. K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30552-3 · Cited by 271
Verhoeff, F. H., Brabin, B. J., Hart, C. A., Chimsuku, L., Kazembe, P., & Broadhead, R. L. (1999) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1999.00349.x · Cited by 236
McGready, R., Lee, S., Wiladphaingern, J., Ashley, E., Rijken, M., Boel, M., Simpson, J., Paw, M., Pimanpanarak, M., Mu, O., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70339-5 · Cited by 228
Desai, M., Gutman, J., L'lanziva, A., Otieno, K., Juma, E., Kariuki, S., Ouma, P., Were, V., Laserson, K., Katana, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00310-4 · Cited by 198
Malaria in pregnancy in the Asia-Pacific region
Rijken, M. J., McGready, R., Boel, M. E., Poespoprodjo, R., Singh, N., Syafruddin, D., Rogerson, S., & Nosten, F. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70315-2 · Cited by 181
Pukrittayakamee, S., Chotivanich, K., Chantra, A., Clemens, R. L., Looareesuwan, S., & White, N. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1329-1334.2004 · Cited by 179
Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174
Management of imported malaria in Europe
Askling, H. H., Bruneel, F., Burchard, G. D., Castelli, F., Chiodini, P. L., Grobusch, M. P., López‐Vélez, R., Paul, M., Petersen, E., Popescu, C. P., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-328 · Cited by 169
van Eijk, A. M., Larsen, D. A., Kayentao, K., Koshy, G., Slaughter, D. E. C., Roper, C., Okell, L. C., Desai, M., Gutman, J., Khairallah, C., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30732-1 · Cited by 160
Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies
Kwenti, T. E. (2018) · Research and Reports in Tropical Medicine · doi:10.2147/rrtm.s154501 · Cited by 144 · cited 1×
“In pregnant women, HIV infection is associated with a significant increase in the prevalence of malaria [63, 64].”
BackgroundMcGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90106-3 · Cited by 114
McGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90235-9 · Cited by 110
Placental Malaria: A New Insight into the Pathophysiology
Sharma, L., & Shukla, G. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00117 · Cited by 105
Duffy, P. E., & Fried, M. (2005) · Springer eBooks · doi:10.1007/3-540-29088-5_7 · Cited by 103 · cited 10×
“The national guidelines and PMI reports of several representative SSA and GMS countries recommend quinine monotherapy for 7 days as the preferred regimen, administered under full supervision, for treating uncomplicated malaria during first trimester (Table 2).”
BackgroundInfluentialPiola, P., Nabasumba, C., Turyakira, E., Dhorda, M., Lindegardh, N., Nyehangane, D., Snounou, G., Ashley, E. A., McGready, R., Nosten, F., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70202-4 · Cited by 99
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria
The PREGACT Study Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508606 · Cited by 99
Clinical Pharmacokinetics of Artemether and Lumefantrine (Riamet??)
̈vre, G. L., & Thomsen, M. S. (1999) · Clinical Drug Investigation · doi:10.2165/00044011-199918060-00006 · Cited by 97
Suthar, A. B., Vitória, M., Nagata, J. M., Anglaret, X., Mbori‐Ngacha, D., Sued, O. G., Kaplan, J. E., & Doherty, M. C. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00005-3 · Cited by 94
Dellicour, S., Sevene, E., McGready, R., Tinto, H., Mosha, D., Manyando, C., Rulisa, S., Desai, M., Ouma, P., Oneko, M., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002290 · Cited by 90
WHO Malaria Policy Advisory Committee and Secretariat (2016) · Malaria Journal · doi:10.1186/s12936-016-1169-x · Cited by 86
Moore, K. A., Simpson, J. A., Paw, M. K., Pimanpanarak, M., Wiladphaingern, J., Rijken, M. J., Jittamala, P., White, N. J., Fowkes, F. J. I., Nosten, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00547-2 · Cited by 84
Diagnosing malaria in pregnancy: An update
Fried, M., Muehlenbachs, A., & Duffy, P. E. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.98 · Cited by 80
Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria
Pukrittayakamee, S., Chantra, A., Vanijanonta, S., Clemens, R., Looareesuwan, S., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2395-2398.2000 · Cited by 73
WHO Malaria Policy Advisory Committee and Secretariat (2015) · Malaria Journal · doi:10.1186/s12936-015-0623-5 · Cited by 72
Obonyo, C., & Juma, E. A. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-2 · Cited by 70
Kloprogge, F., Workman, L., Borrmann, S., Teketé, M., Lefèvre, G. Y., Hamed, K. A., Piola, P., Ursing, J., Kofoed, P., Mårtensson, A., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002579 · Cited by 70
Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy
Sevene, E., González, R., & Menéndez, C. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003733599 · Cited by 66
Treating Severe Malaria in Pregnancy: A Review of the Evidence
Kovacs, S. D., Rijken, M. J., & Stergachis, A. (2015) · Drug Safety · doi:10.1007/s40264-014-0261-9 · Cited by 66
Disposition of oral quinine in acute falciparum malaria
Supanaranond, W., Davis, T. M. E., Pukrittayakamee, S., Silamut, K., Karbwang, J., Molunto, P., Chanond, L., & White, N. J. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315138 · Cited by 63
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
Saito, M., Gilder, M. E., McGready, R. M., & Nosten, F. H. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1535593 · Cited by 58
Chan, X. H. S., Win, Y. N., Mawer, L. J., Tan, J. Y., Brugada, J., & White, N. J. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30297-4 · Cited by 54
Yeka, A., Achan, J., D’Alessandro, U., & Talisuna, A. O. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70109-4 · Cited by 52
Treatment of uncomplicated and severe malaria during pregnancy
D’Alessandro, U., Hill, J., Tärning, J., Pell, C. L., Webster, J., Gutman, J., & Sevene, E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30065-3 · Cited by 49
Amankwah, S., & Anto, F. R. (2019) · Journal of Tropical Medicine · doi:10.1155/2019/9278432 · Cited by 49
Tärning, J., Kloprogge, F., Dhorda, M., Jullien, V., Nosten, F. H., White, N. J., Guerin, P. J., & Piola, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-13 · Cited by 48
Mosha, D., Guidi, M., Mwingira, F., Abdulla, S., Mercier, T., Decosterd, L. A., Csajka, C., & Genton, B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02595-14 · Cited by 43
WHO Malaria Policy Advisory Committee and Secretariat (2015) · Malaria Journal · doi:10.1186/s12936-015-0787-z · Cited by 43
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D'Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30064-5 · Cited by 39
ADEGNIKA, A. A., BREITLING, L. P., AGNANDJI, S. T., CHAI, S. K., SCHÜTTE, D., OYAKHIROME, S., SCHWARZ, N. G., GROBUSCH, M. P., MISSINOU, M. A., RAMHARTER, M., et al. (2005) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.263 · Cited by 38
Saito, M., Gilder, M. E., Nosten, F. H., McGready, R. M., & Guerin, P. J. (2017) · Malaria Journal · doi:10.1186/s12936-017-2135-y · Cited by 35
Kovacs, S., van Eijk, A. M., Sevene, E., Dellicour, S., Weiss, N. S., Emerson, S. S., Steketee, R. W., ter Kuile, F. O., & Stergachis, A. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164963 · Cited by 33
Tun, K. M., Jeeyapant, A., Myint, A. H., Kyaw, Z. T., Dhorda, M., Mukaka, M., Cheah, P. Y., Imwong, M., Hlaing, T., Kyaw, T. T., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2404-4 · Cited by 33
Malaria in pregnancy: diagnosing infection and identifying fetal risk
Conroy, A. L., McDonald, C. R., & Kain, K. C. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.123 · Cited by 32
Onyamboko, M. A., Hoglund, R. M., Lee, S. J., Kabedi, C., Kayembe, D. K., Badjanga, B. B., Turner, G. D. H., Jackson, N. V., Tärning, J., McGready, R. M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01140-19 · Cited by 29
Burger, R. J., van Eijk, A. M., Bussink, M., Hill, J., & ter Kuile, F. O. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv170 · Cited by 27
Ogutu, B. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.771167 · Cited by 25
Manyando, C., Njunju, E. M., Virtanen, M., Hamed, K. A., Gomes, M. F., & Geertruyden, J. V. (2015) · Malaria Journal · doi:10.1186/s12936-015-0578-6 · Cited by 24
Ballard, S.-B., Salinger, A., MPHc, Arguin, P. M., Desai, M., & Tan, K. R. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6714a4 · Cited by 24 · cited 1×
“However, when neither of these options is available, AL should be considered for treatment [36].”
BackgroundSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01592-z · Cited by 23
Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy
Nosten, F., ter Kuilei, F., Lay Thwai, K., Maelankirri, L., & White, N. J. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90139-h · Cited by 17
Nath, A. (2021) · Epidemiology International · doi:10.24321/2455.7048.202116 · Cited by 1
Research works printed but not linked: 2
- WHO. Guidelines for the treatment of malaria, 2nd Edn. Geneva, World Health Organization, 2010. https://www.ncbi.nlm.nih.gov/books/NBK254223/. Accessed 5 Jun 2020.
- Management Sciences for Health (MSH)/WHO. International Medical Products Price Guide. 2015 edition. https://www.msh.org/sites/default/files/msh-2015-international-medical-products-price-guide.pdf. Accessed 7 Jun 2020.
Cited by
Armando, C. J., Rocklöv, J., Sidat, M., Tozan, Y., Mavume, A. F., Bunker, A., & Sewe, M. O. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1162535 · Cited by 68
Current update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Kalu, F. A., & Chukwurah, J. N. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04804-x · Cited by 30
“Studies have found that (prophylactic) treatment for malaria in countries with moderate to high prevalence of malaria helps to inhibit or minimize the effects of malarial parasites on the red blood cells, thus reducing the risks of maternal anaemia, placental malaria, preterm birth and pregnancy loss [1, 38, 39].”
BackgroundRe-orienting anti-malarial drug development to better serve pregnant women
Gaaloul, M. E., Tornesi, B. M., Lebus, F., Reddy, D., & Kaszubska, W. (2022) · Malaria Journal · doi:10.1186/s12936-022-04137-2 · Cited by 24
Adams, L., Afiadenyo, M., Kwofie, S. K., Wilson, M. D., Kusi, K. A., Obiri‐Yeboah, D., Moane, S., & McKeon‐Bennett, M. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100447 · Cited by 27
Metadata
- Authors
- Al Khaja, K. A. J., & Sequeira, R. P.
- Affiliations
- Arabian Gulf University (BH)
- Venue
- Malaria Journal
- Published
- 2021-01-23
- Volume
- 20
- Issue
- 1
- Pages
- 62-62
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC7825227
- OpenAlex
- W3121915585
- Cited by
- 39
- References
- 54
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 12 · 2023: 7 · 2022: 6 · 2021: 3
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- malaria in pregnancy, Plasmodium falciparum, chloroquine resistance, national treatment guidelines, WHO guidelines, artemether-lumefantrine, artesunate, sulfadoxine-pyrimethamine, intermittent preventive treatment, quinine, HIV coinfection, folic acid supplementation, guideline adherence, President's Malaria Initiative, malaria prevention in pregnancy
- MeSH terms
- Artesunate, Artemether, Artemether, Lumefantrine Drug Combination, Adult, Antimalarials, Chloroquine, Drug Combinations, Female, Humans, Malaria, Pregnancy, Pyrimethamine, Quinine, Sulfadoxine, Pregnancy Complications, Parasitic, Practice Guidelines as Topic, Parasitemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.